Responsible for corporate venture investments in the United States, from seed to IPO. Responsibilities also include board positions, developing strategic business partnerships, M&A, licensing, facilitating collaborations, and launching new business initiatives, including joint ventures and new company formation.

Responsible for the development of strategic business partnerships, licensing and M&A opportunities, collaborations, investment, and new business initiatives including joint ventures, and newco formation.

Facilitated the translation of university research and technology by driving the development of new ventures. • Launched over 40 life science startups from faculty research. Developed intellectual property strategy, pitch decks and investment materials that led to over $100M in financing for startups.• Negotiated licensing and partnership agreements with public biopharma companies and leading research institutes.

Business and financing strategy for public and private financings and cross-border transactions, including M&A, licensing, strategic partnerships, and spinouts in the life science and biopharma sectors. • Provided scientific, regulatory, and intellectual property diligence on various technologies across diverse fields of life science and healthcare.• Advised clients on financing, clinical design and development, and exit strategies. Created financial models, slide decks, and executive summaries.• Performed diligence and valuation modeling for M&A transactions. Engaged with pharmaceutical partners for licensing and M&A deals for banking clients. • Supported investments for over $100M in private financing, assisted in closing over $32 M in public equity financing, and lead multiple M&A transactions totaling over $80M for life science and biopharma companies.

Specialized in venture investments and strategic development within the biopharma and life sciences sectors, my role encompassed rigorous due diligence, detailed investment analysis, and the nurturing of innovative healthcare initiatives. Key responsibilities and achievements included:• Led comprehensive due diligence and opportunity reviews, including presenting over 400 companies to investment partners and closing $20 million in limited partnership funding.• Authored investment memorandums with in-depth competitive and ROI analysis, coupled with portfolio analysis and modeling, to guide strategic investment decisions.• Supported the launch of a new venture company focused on Alzheimer's diagnostics and prognostics for the pending approval of antibody therapeutics.

Responsible for business and product development efforts for a portable hand-held medical diagnostic platform to serve the rapidly growing point‐of‐care testing market. Led licensing negotiations for two technology platforms from Harvard University and the University of California, Davis.

Immune-oncology therapeutics company developing bifunctional nanoparticles. Cancer vaccine approach leveraging targeted nanoparticles with patterned alpha-gal epitope combined with various cancer antigens, to elicit directed immune response for solid tumors.

Developed the initial business plan of a lab-on-a-chip for drug discovery company. • Coordinated investment from accredited angel investors• Researched mixing chambers and designed layout masks for microfluidic devices

Responsible for daily operations of a nanomaterials start-up company growing from 5 to 30 staff scientists within 2 years.• Assisted with the authoring of an investment prospectus and managed private placement from accredited investors totally $1.2 million• Researched metallic coatings using scanning tunneling microscopy for development of micro-portable single molecule chemical detector using surface enhanced raman spectroscopy for homeland security applications.